[Progress in the drug therapy of cancer].
D000903:Antibiotics, Antineoplastic / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D001215:Asparaginase / Q000627:therapeutic use; D003561:Cytarabine / Q000627:therapeutic use; D003630:Daunorubicin / Q000627:therapeutic use; D004357:Drug Synergism; D006801:Humans; D006834:Hydrazines; D006918:Hydroxyurea / Q000627:therapeutic use; D009369:Neoplasms; D009603:Nitroso Compounds; D010848:Picolinic Acids / Q000627:therapeutic use; D011748:Pyrogallol / Q000627:therapeutic use; D011804:Quinolines / Q000627:therapeutic use; D013308:Streptonigrin / Q000627:therapeutic use; D014508:Urea
D000903:Antibiotics, Antineoplastic; D000970:Antineoplastic Agents; D006834:Hydrazines; D009603:Nitroso Compounds; D010848:Picolinic Acids; D011804:Quinolines; D011748:Pyrogallol; D003561:Cytarabine; D013308:Streptonigrin; D014508:Urea; D001215:Asparaginase; D006918:Hydroxyurea; D003630:Daunorubicin
Fortschritte in der medicamentösen Krebsbehandlung.